X4 PHARMACEUTICALS, INC (XFOR) Gross margin 2024–2025
X4 PHARMACEUTICALS, INC (XFOR) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.6%FY2025 · since FY2024: 68.8% → 83.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.6% | +14.8 pp |
| FY2024 | 68.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice